Top Markets
Coin of the day
Conformis, Inc. Conformis, Inc.

Conformis, Inc.

CFMS
Rang in aandelen #33990
Conformis, Inc., established in Billerica, Massachusetts in 2004, functions as... Conformis, Inc., established in Billerica, Massachusetts in 2004, functions as a medical technology enterprise that designs, produces, and commercializes custom-fit medical devices and surgical instruments. Their product portfolio encompasses a variety of personalized knee replacement systems, including iUni and iDuo for addressing unicompartmental or bicompartmental knee osteoarthritis, the iTotal CR for cruciate-retaining total knee procedures, the iTotal PS for posterior-stabilized total knee replacements, as well as the iTotal Identity and Identity Imprint lines. Additionally, the company offers hip replacement options like the Conformis Hip System and Cordera products, and provides iJigs, which are personalized, single-use surgical guides. Conformis distributes these specialized solutions to orthopedic surgeons, hospitals, and other medical facilities through its dedicated sales force, independent representatives, and distributors, serving markets across the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, the United Arab Emirates, Oman, Italy, Poland, and other global regions.
Aandeelprijs
$2.26
Laatst gesynchroniseerd: 2023-09-14
Marktkapitalisatie
$6.44M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Conformis, Inc. (CFMS)

Categorie

Dividendrendementgeschiedenis voor Conformis, Inc. (CFMS)
Het dividendrendement (TTM) van Conformis, Inc. (aandelsymbool: CFMS) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Conformis, Inc. (CFMS) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten